Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ANDEMBRY safely and effectively. See full prescribing information for ANDEMBRY. ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use Initial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
ANDEMBRY is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
- generic_name
- garadacimab
- product_names
- Garadacimab
- ndc
- 63833-925, 63833-925-20, 63833-925-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en